{
    "nctId": "NCT02593409",
    "officialTitle": "HIV Pre-Exposure Prophylaxis Priming of Immune Effectors",
    "inclusionCriteria": "* age \u226518 at screening\n* not intending to move away from the clinic's catchment area for the next 2 years\n* HIV-1 antibody negative\n* reports commercial sex work\n* contact information is provided\n* written informed consent\n* Must be FEMALE\n* Must have minimum age of 18 Years",
    "exclusionCriteria": "* HIV infection at screening\n* participation in previous or concurrent HIV vaccine trials\n* lactating, pregnant or planning pregnancy\n* renal function impairment (serum creatinine \\>1.5 mg/dl), Fanconi syndrome\n* abnormal liver function tests (AST/ALT \\> 43 U/L), liver disease, viral hepatitis, hepatitis B virus (HBV) infection\n* serum phosphorus \\<2.2mg/dl, osteoporosis\n* known sensitivity to components of the Truvada\u00ae formulation\n* any immunosuppressive treatment, such as systemic corticosteroids\n* assumption of medication that interacts with Truvada\u00ae\n* high likelihood of poor adherence to PREP and clinic attendance\n* any condition that in the opinion of the attending physician could endanger the health of the participant or render her unsuitable to participate in the trial"
}